DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bw3zl5/benchmarking_the) has announced the addition of the "Benchmarking the Pharma Industry's HEOR Functions" report to their offering.
Informing the drug development and commercialization industry
This study surveyed 106 pharmaceutical and biotechnology professionals about their experiences with 27 small, mid-size, and large Phase IV CROs. Together, these responses provide insight into 208 unique service encounters.
According to the respondents, UBC's project manager quality' and therapeutic expertise' were two of the seven staff characteristics that set their staff apart and earned them this top rank as industry leaders, explained Kevin Olson, CEO of Industry Standard Research. When it comes to global, logistically challenging studies, Olson continued, an aspect that sponsors indicate is growing in importance is the local market / regulatory knowledge'. The respondents have indicated that Quintiles has a strong grasp of this area.
Respondents rated 27 CROs across 26 different staff, operational, and organizational service quality attributes. These include: Overall Value, Low Cost, and Prior Positive Experience with Service Provider, among others. The 27 Phase IV CROs included in this report are: Accelovance, Aptiv Solutions, BioClinica, Charles River Laboratories, Chiltern, Cognizant, Covance, DaVita Clinical Research, DCRI - Duke, Eurofins, ICON, INC Research, inVentiv Health Clinical, Medpace, Novella, PAREXEL, PPD, PRA, Premier Research, Quintiles, Mapi, RPS, SGS, Tata, Theorem, UBC, and Worldwide Clinical Trials.
This report has two simple missions: help sponsor companies make more informed CRO selection decisions and help service providers optimize their operational and marketing strategies. The 208 unique service encounters provide a valuable tool that will help sponsor/ CRO relationships run as effectively and as efficiently as possible, stated Olson.
Key Topics Covered:
- Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
- Service Provider Selection Drivers
- Service Provider Performance and Scorecards Across Attributes
- Outcome Measures: EPI and Customer Loyalty
- Company Service Quality Profiles
- Phase IV Study Data
- Service Quality Drill-Downs
- Summary of EPI
- Service Provider Loyalty
- Service Providers Drill-downs
- Cross-service provider performance
- Speed of Site/ Investigator Recruitment
- Respondent Demographics
For more information visit http://www.researchandmarkets.com/research/bw3zl5/benchmarking_the